You just read:

Amsterdam Molecular Therapeutics Announces European Commission Delays Decision on Glybera® Marketing Authorisation And Requests Further Information From the CHMP

News provided by

Amsterdam Molecular Therapeutics (AMT) B.V

30 Jan, 2012, 06:00 GMT